Introduction

When comparing Medical Devices Rules 2017 vs 2026, manufacturers and importers should understand how regulatory requirements and compliance practices have evolved in India.

Medical Devices Rules 2017 and 2026 are important for manufacturers, importers, authorised agents, and other medical device businesses operating in India. The Medical Devices Rules, 2017 continue to provide the core regulatory framework, but the practical compliance environment has evolved through amendments, notifications, classification updates, licensing developments and digital regulatory processes. In 2026, businesses need to look beyond the original text of MDR 2017 and understand the latest applicable CDSCO requirements for their specific device, risk class, and business activity.

This guide explains the major differences between the Medical Devices Rules 2017 and 2026 regulatory environments, helping businesses understand what has changed and what they should review before manufacturing, importing or marketing a medical device in India.

Quick Answer: What Is the Difference Between Medical Devices Rules 2017 vs 2026

The key point is that 2026 is not necessarily a completely new standalone replacement rulebook for MDR 2017. Instead, MDR 2017 remains the foundation of India’s medical device regulatory framework, while the requirements applicable in 2026 reflect subsequent amendments, notifications, developments in device classification, and CDSCO implementation updates. Therefore, businesses should assess the current regulatory position rather than relying only on the original 2017 text.

What Were the Medical Devices Rules 2017?

The Medical Devices Rules, 2017, were introduced to establish a structured and risk-based regulatory framework for medical devices in India. The rules cover important areas such as device classification, manufacturing, import, licensing, quality systems, clinical investigations, labelling and post-market responsibilities.

The framework classifies medical devices into four risk categories:

• Class A – Low Risk
• Class B – Low to Moderate Risk
• Class C – Moderate to High Risk
• Class D – High Risk

The level of regulatory oversight generally increases with the risk associated with the medical device.

Medical Devices Rules 2017 vs 2026 – Key Changes at a Glance

The exact requirements can differ based on the individual device and its classification, so businesses should verify the latest official position before filing an application.

1. Medical Device Classification Has Become More Important

Understanding Medical Devices Rules 2017 vs 2026 is important for correct device classification and regulatory compliance.

One of the biggest practical developments in the Medical Devices Rules 2017 vs 2026 comparison is the increased importance of correct device classification. Under the risk-based framework, a device may fall within Class A, B, C, or D, and the classification can directly affect the licensing authority, documentation, regulatory pathway, and level of scrutiny.

Manufacturers and importers should not assume that an older classification remains correct. The device’s generic name, intended use, technological characteristics, and applicable CDSCO classification information should be checked before submitting an application.

What businesses should do:

• Verify the latest classification of the device.
• Review the intended use carefully.
• Check whether the device appears in the current classification information.
• Confirm the applicable regulatory authority.
• Avoid submitting an application based on outdated classification assumptions.

2. More Medical Devices Are Moving Towards Formal Regulatory Coverage

The MDR 2017 framework established the basis for bringing medical devices under a more comprehensive regulatory system. Subsequent notifications and classification developments have made it increasingly important for manufacturers and importers to determine whether their products are now subject to specific licensing or registration requirements.

For 2026 compliance, businesses should not rely solely on whether a product was previously considered “unregulated” or outside a particular notification. The current status of the device should be verified using the latest applicable regulatory information.

3. Licensing Requirements Under Medical Devices Rules 2017 vs 2026

Under Medical Devices Rules 2017 vs 2026, licensing requirements may vary according to the device category and risk classification.

The licensing pathway depends on factors such as:

• Device risk classification
• Whether the device is manufactured in India or imported
• Type of medical device or IVD
• Intended use
• Applicable regulatory authority
• Current notifications and exemptions

In India, regulatory responsibilities can involve the Central Licensing Authority/CDSCO and State Licensing Authorities depending on the applicable device category and activity. This means there is no single universal “medical device registration” process that applies identically to every product.

4. Class A Device Requirements Have Evolved

For businesses comparing MDR 2017 vs 2026, Class A medical devices require special attention because certain low-risk devices may be subject to specific regulatory treatment. For example, the regulatory position for eligible Class A non-sterile, non-measuring devices has included specific exemptions or self-notification arrangements under applicable notifications.

However, an exemption from a particular licensing process should not be treated as a complete exemption from all regulatory obligations. Manufacturers and importers must still ensure that their device correctly meets the applic

5. Digital CDSCO Systems Have Changed the Compliance Process

The 2026 regulatory environment places greater emphasis on digital regulatory processes. Businesses may need to use the applicable CDSCO online system for activities such as applications, classification-related pr and regulatory documentation.

This makes accurate digital submissions increasingly important. Common issues such as incorrect device names, inconsistent intended use, outdated documents, or mismatched information can create avoidable regulatory delays.

6. Documentation Requirements Need to Be More Device-Specific

Businesses should review Medical Devices Rules 2017 vs 2026 to ensure their technical documentation meets current compliance requirements.

Under the current regulatory environment, documentation should be prepared according to the specific device and applicable pathway. Depending on the application, documentation may include:

• Device description
• Intended use
• Device Master File
• Site or Plant Master File
• Quality management documentation
• Labels and Instructions for Use
• Essential Principles checklist
• Test and performance information
• Clinical or performance evidence, where applicable
• Adverse event and safety information

The documentation should be consistent across all records and should accurately reflect the device being submitted for regulatory approval

7. Quality and Safety Compliance Remain Central to MDR 2017 vs 2026

Although the regulatory system has evolved, the fundamental objective remains unchanged: medical devices placed on the Indian market should meet applicable standards of safety, quality, and performance.

In 2026, manufacturers and importers should take a lifecycle approach to compliance. Regulatory responsibility does not necessarily end when a licence or approval is obtained. Businesses should also monitor:

• Product quality
• Labelling compliance
• Complaint handling
• Adverse events
• Field safety actions
• Changes to the device
• Changes in manufacturing processes
• Regulatory renewals or ongoing obligations, where applicable

8. Post-Market Compliance Is Becoming Increasingly Important

Medical device compliance should continue after the product enters the market. Companies should maintain systems for monitoring product performance and responding appropriately to complaints, incidents, and safety concerns.

A strong post-market compliance process can help businesses identify potential regulatory issues early and maintain better control over product safety and quality.

Who Is Affected by Medical Devices Rules 2017 vs 2026 Changes?

The evolving regulatory environment may affect:

Medical Device Manufacturers

Indian manufacturers should verify their current licensing requirements, quality systems, classification, and documentation.

Medical Device Importers

Importers should confirm the correct import pathway and ensure that the required documentation and authorised representation arrangements are in place.

Foreign Manufacturers

Foreign manufacturers entering the Indian market should carefully review the applicable Indian regulatory pathway and documentation requirements.

Indian Authorised Agents

Authorised agents should ensure that manufacturer information, technical documentation and regulatory submissions remain accurate and current.

IVD Manufacturers and Importers

IVD products are also regulated through a risk-based system, and the applicable classification and regulatory requirements should be assessed separately where necessary

Medical Devices Rules 2017 vs 2026 – What Should Businesses Do Now?

To stay prepared for the current regulatory environment, businesses should follow this checklist:

1. Confirm Your Product Is Correctly Identified

Clearly define the product, intended use, variants, and accessories.

2. Verify the Current Risk Classification

Check whether the device falls under Class A, B, C, or D.

3. Review the Latest Applicable Regulatory Requirements

Do not rely only on old guidance or historical approval processes.

4. Identify the Correct Licensing Pathway

The applicable process may differ for manufacturing, import, and other activities.

5. Update Technical Documentation

Ensure the Device Master File, quality records, labels, and supporting evidence are current and consistent.

6. Review Post-Market Obligations

Maintain appropriate processes for complaints, safety issues, and regulatory reporting.

7. Monitor CDSCO Updates

Medical device regulation can evolve through notifications, amendments, circulars, and classification updates, so ongoing monitoring is essential

Common Mistakes to Avoid in 2026

Businesses should avoid these common mistakes:

• Using outdated MDR 2017 information without checking later updates.
• Selecting the wrong risk classification.
• Assuming every medical device follows the same registration process.
• Treating an old regulatory position as permanently applicable.
• Submitting inconsistent technical documents.
• Ignoring changes in intended use or product design.
• Assuming that a Class A exemption applies to every low-risk device.
• Failing to monitor post-market compliance.
• Relying only on unofficial information instead of verifying the current official position.

The Future of Medical Device Regulation in India

The direction of India’s medical device regulatory framework is toward greater clarity, broader device coverage, risk-based regulation and stronger digital compliance processes. MDR 2017 remains central to this framework, while subsequent regulatory developments continue to shape how manufacturers and importers comply in practice.

For this reason, the best approach in 2026 is not simply to ask whether MDR 2017 has been replaced. Businesses should ask: What is the latest applicable regulatory requirement for my specific medical device today?

Conclusion

The comparison between Medical Devices Rules 2017 vs 2026 shows that the original MDR 2017 framework remains highly important, but businesses must now consider the regulatory developments that have occurred since its introduction. Changes in classification practices, expanding regulatory coverage, licensing processes, digital systems, documentation expectations, and compliance monitoring have made it essential to review the current position before taking regulatory action.

Whether you manufacture, import or represent medical devices in India, correct classification and up-to-date regulatory verification should be the starting point. A proactive compliance strategy can help reduce delays and support smoother access to the Indian medical device market.

FAQs About Medical Devices Rules 2017 vs 2026

Q1. What is the main difference between the Medical Devices Rules 2017 and 2026?

The Medical Devices Rules, 2017 remain the core regulatory framework, while the 2026 compliance environment reflects later amendments, notifications, classification developments and CDSCO implementation updates.

Q2. Have the Medical Devices Rules 2017 been completely replaced in 2026?

Businesses should not assume that there is a single completely new replacement framework called “Medical Devices Rules 2026.” MDR 2017 remains the legal foundation, subject to applicable later regulatory updates.

Q3. What are the four medical device risk classes in India?

Medical devices are generally classified as Class A, Class B, Class C, and Class D based on their level of risk.

Q4. Why is medical device classification important in 2026?

Classification can affect the applicable licensing authority, documentation, regulatory pathway, and level of regulatory scrutiny.

Q5. Do all medical devices require the same CDSCO registration process

No. The applicable process depends on the device, risk class, intended use, manufacturing or import activity and current regulatory requirements.

Q6. What has changed for Class A medical devices?

Certain eligible Class A non-sterile, non-measuring devices may be subject to specific exemptions or self-notification arrangements, depending on the applicable regulatory conditions.

Q7. Do imported medical devices need regulatory approval in India?

Imported medical devices must follow the applicable Indian regulatory pathway, which can depend on the specific device and its current regulatory status.

Q8. What documents are required for medical device regulatory applications?

Depending on the application, documents may include device information, technical documentation, quality records, labels, Instructions for Use and other supporting evidence.

Q9. What should manufacturers do before applying for a medical device licence?

Manufacturers should first confirm the device’s regulatory status, risk classification, applicable licensing pathway, and required documentation.

Q10. How can businesses stay updated with CDSCO medical device regulations?

Businesses should regularly monitor official CDSCO notifications, classification information, applicable regulatory circulars, and other current government updates.